EUVIMEDEUVIMED entdecken
MetaanalyseSystematische ÜbersichtOpen Access · CC BY-NC-ND 4.0

Gut microbiota changes in patients with hypertension: A systematic review and meta‐analysis

Meiling Cai, Lingyu Lin, Fei Jiang, Yanchun Peng, Sailan Li, Liangwan Chen, Yanjuan Lin iD

The Journal of Clinical Hypertension · 2023-12 · 25 (12) · 1053-1068

DOI: 10.1111/jch.14722 ↗

Kurz gefasst

Metaanalyse in der Zeitschrift The Journal of Clinical Hypertension, online erschienen am 18.10.2023. Verfasst von Meiling Cai und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nursing, Fujian Medical University Union Hospital, Fuzhou, China. Hauptthemen laut MEDLINE: Hypertension, Gastrointestinal Microbiome. Die Arbeit wurde bisher 53-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: The Medical Innovation Project of Fujian Provincial Health Commission, Guiding Project of Fujian Science and Technology, Fujian Provincial Special Reserve Talents Laboratory (Fujian Medical University Union Hospital).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hypertension is a major public health issue worldwide. The imbalance of gut microbiota is thought to play an important role in the pathogenesis of hypertension. The authors conducted the systematic review and meta‐analysis to clarify the relationship between gut microbiota and hypertension through conducting an electronic search in six databases. Our meta‐analysis included 19 studies and the results showed that compared with healthy controls, Shannon significantly decreased in hypertension [ SMD = −0.13, 95% CI (−0.22, −0.04), p = .007]; however, Simpson [ SMD = −0.01, 95% CI (−0.14, 0.12), p = .87], ACE [ SMD = 0.18, 95% CI (−0.06, 0.43), p = .14], and Chao1 [ SMD = 0.11, 95% CI (−0.01, 0.23), p = .08] did not differ significantly between hypertension and healthy controls. The F/B ratio significantly increased in hypertension [ SMD = 0.84, 95% CI (0.10, 1.58), p = .03]. In addition, Shannon index was negatively correlated with hypertension [ r = −0.12, 95% CI (−0.19, −0.05)], but had no significant correlation with SBP [ r = 0.10, 95% CI (−0.19, 0.37)] and DBP [ r = −0.39, 95% CI (−0.73, 0.12)]. At the phylum level, the relative abundance of Firmicutes [ SMD = −0.01, 95% CI (−0.37, 0.34), p = .94], Bacteroidetes [ SMD = −0.15, 95% CI (−0.44, 0.14), p = .30], Proteobacteria [ SMD = 0.25, 95% CI (−0.01, 0.51), p = .06], and Actinobacteria [ SMD = 0.21, 95% CI (−0.11, 0.53), p = .21] did not differ significantly between hypertension and healthy controls. At the genus level, compared with healthy controls, the relative abundance of Faecalibacterium decreased significantly [ SMD = −0.16, 95% CI (−0.28, −0.04), p = .01], while the Streptococcus [ SMD = 0.20, 95% CI (0.08, 0.32), p = .001] and Enterococcus [ SMD = 0.20, 95% CI (0.08, 0.33), p = .002] significantly increased in hypertension. Available evidence suggests that hypertensive patients may have an imbalance of gut microbiota. However, it still needs further validation by large sample size studies of high quality.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HypertensionGastrointestinal MicrobiomeHumans

Stichwörter der Autor:innen

gut microbiotahigh throughput sequencinghypertensionmeta-analysissystematic review

Autor:innen und Institutionen

  • Department of Nursing, Fujian Medical University Union Hospital, Fuzhou, China.
  • Department of Cardiovascular Surgery, Fujian Medical University Union Hospital, Fuzhou, China.
  • Fujian Provincial Special Reserve Talents Laboratory, Fujian Medical University Union Hospital, Fuzhou, China.

ORCID-Profile: Yanjuan Lin

Förderung

  • The Medical Innovation Project of Fujian Provincial Health Commission
  • Guiding Project of Fujian Science and Technology
  • Fujian Provincial Special Reserve Talents Laboratory (Fujian Medical University Union Hospital)
  • Key Laboratory of Cardio-Thoracic Surgery (Fujian Medical University)
  • Fujian Province University

Zitieren

APA

Cai, M., Lin, L., Jiang, F., Peng, Y., Li, S., Chen, L., & Lin, Y. (2023). Gut microbiota changes in patients with hypertension: A systematic review and meta‐analysis. The Journal of Clinical Hypertension, 25(12), 1053-1068. https://doi.org/10.1111/jch.14722

Vancouver

Cai M, Lin L, Jiang F, Peng Y, Li S, Chen L, et al. Gut microbiota changes in patients with hypertension: A systematic review and meta‐analysis. The Journal of Clinical Hypertension. 2023;25(12):1053-1068. doi:10.1111/jch.14722

BibTeX
@article{Cai2023,
  author = {Cai, Meiling and Lin, Lingyu and Jiang, Fei and Peng, Yanchun and Li, Sailan and Chen, Liangwan and Lin, Yanjuan},
  title = {Gut microbiota changes in patients with hypertension: A systematic review and meta‐analysis},
  journal = {The Journal of Clinical Hypertension},
  year = {2023},
  volume = {25},
  number = {12},
  pages = {1053--1068},
  doi = {10.1111/jch.14722}
}
Kostenlos starten →